← Leaderboards
Steven Roth
University Of Chicago
$7,696,385
Attributed
$8,698,438
Total exposure
5
Grants
5
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $866.6K · FY2006–25$1M$750K$500K$250K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$8,698,438 · 5
By mechanism
R01$7,733,341 · 3
R21$965,097 · 2
Top collaborators
- Sriram Ravindran7 shared
Most similar at University Of Chicago
Same institution · by research overlap
- Matthew Lee Wohlever$2,276,308
- Benjamin Derman$659,279
- Shyam Prabhakaran$10,272,904
- Robert Arnulfo Carrillo$3,432,865
- Colin Sheehan$96,668
Others in their field
Top investigators on “Blindness”
- Randall J Bateman · Washington University$137,189,188
- John M Lachin · George Washington University$122,970,601
- David M Nathan · Massachusetts Institute Of Technology$118,921,924
- Beth Baseler · Leidos Biomedical Research, Inc.$111,479,515
- Judith S Hochman · New York University School Of Medicine$100,149,457
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$96,562,493
Research focus
BlindnessRetinaInnovationPreventIschemiaIn VivoNeuroprotectionHypoxiaRetinal IschemiaRetinal DiseasesApoptosisInjuryPathway InteractionsDiabetic RetinopathyInflammationRetinal Ganglion CellsCellsCell DeathExtracellular VesiclesMolecularEventEngineeringInflammatoryAttenuated
Grant awards (30)
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$449,165
R01 · FY2025 · EY · contact PI
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$480,304
R01 · FY2024 · EY · contact PI
VRC: Engineered extracellular vesicles for mild TBI-induced retinal injury$312,420
R01 · FY2024 · EY · contact PI
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$34,369
R01 · FY2024 · EY · contact PI
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$480,304
R01 · FY2023 · EY · contact PI
VRC: Engineered extracellular vesicles for mild TBI-induced retinal injury$317,596
R01 · FY2023 · EY · contact PI
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$51,555
R01 · FY2023 · EY · contact PI
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$17,186
R01 · FY2023 · EY · contact PI
Mesenchymal stem cell extracellular vesicles for ischemic retinal damage$491,224
R01 · FY2022 · EY · contact PI
VRC: Engineered extracellular vesicles for mild TBI-induced retinal injury$337,600
R01 · FY2022 · EY · contact PI
Novel Cell Free Therapy for Glaucoma$249,661
R21 · FY2020 · EY · contact PI
Novel Cell Free Therapy for Glaucoma$32,375
R21 · FY2020 · EY · contact PI
Novel Cell Free Therapy for Glaucoma$195,009
R21 · FY2019 · EY · contact PI
Risk factor anaylysis of perioperative visual loss$211,122
R21 · FY2018 · EY · contact PI
Risk factor anaylysis of perioperative visual loss$25,012
R21 · FY2018 · EY · contact PI
Risk factor anaylysis of perioperative visual loss$251,918
R21 · FY2017 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$382,200
R01 · FY2014 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$370,500
R01 · FY2013 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$390,000
R01 · FY2012 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$368,896
R01 · FY2010 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$372,621
R01 · FY2009 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$174,174
R01 · FY2009 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$365,169
R01 · FY2008 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$372,621
R01 · FY2007 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$382,917
R01 · FY2006 · EY · contact PI
The Role of Adenosine in Retinal Ischemia$381,250
R01 · FY2004 · EY
The Role of Adenosine in Retinal Ischemia$381,250
R01 · FY2003 · EY
The Role of Adenosine in Retinal Ischemia$365,500
R01 · FY2002 · EY
ADENOSINE AND RETINAL ISCHEMIA$200,034
R01 · FY2001 · EY
ADENOSINE AND RETINAL ISCHEMIA$254,486
R01 · FY2000 · EY